Company news
Firebrick Pharma Limited news in 2022
Firebrick Pharma Limited's news releases, calls and decks from 2022, newest first.
Nasodine Composition Patent Accepted in Australia
November 13, 2022
Firebrick Receives $1.08m R&D Tax Incentive
November 8, 2022
September 2022 Quarterly Activity Report & Appendix 4C
October 31, 2022
Appendix 4E & Annual Report
August 23, 2022
June 2022 Quarterly Activity Report & Appendix 4C
July 28, 2022
Outcome of s60 appeal for Nasodine and next steps
July 7, 2022
Firebrick starts Phase 3 common cold trial of Nasodine
May 3, 2022
March 2022 Quarterly Activity Report & Appendix 4C
April 26, 2022
Firebrick starts COVID-19 trial of Nasodine
April 26, 2022
31 December Interim Financial Report & Appendix 4D
February 11, 2022
Decks in 2022
- Shareholder Meeting (November 2022)
Shareholder meeting · 28 slides · Nov 23, 2022
- Euroz Hartleys Rottnest Island Institutional Conference 2022
Conference · 13 slides · Mar 11, 2022